← Back to Search

FOLLOW UP VISIT-TELEMEDICINE for Breast Cancer

N/A
Waitlist Available
Led By Eleni Stavrou, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

This trial is comparing the experiences of patients who have telemedicine visits with those who have face-to-face visits, to understand when it is appropriate to conduct visits remotely.

Eligible Conditions
  • Breast Cancer
  • Prostate Cancer
  • Patient Engagement
  • Patient Preference
  • Patient Satisfaction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Experience Comparison
Secondary outcome measures
Clinician Experience Comparison
Clinician Preference
Health system use Comparison
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: FOLLOW UP VISIT-TELEMEDICINEExperimental Treatment1 Intervention
After initial in-person routine followup care, participants will be randomly assigned to receive telemedicine care delivery for their subsequent follow up appointment. Participants will complete a survey after each visit.
Group II: FOLLOW UP VISIT-FACE TO FACEExperimental Treatment1 Intervention
After initial in-person routine followup care, participants will be randomly assigned to receive face-to-face care delivery for their subsequent follow up appointment. Participants will complete a survey after each visit.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FOLLOW UP VISIT-TELEMEDICINE
2021
N/A
~30
FOLLOW UP VISIT-FACE TO FACE
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,079 Previous Clinical Trials
340,950 Total Patients Enrolled
141 Trials studying Breast Cancer
22,587 Patients Enrolled for Breast Cancer
Eleni Stavrou, MDPrincipal InvestigatorDana-Farber Cancer Institute
Christopher Manz, MD, MSHPPrincipal InvestigatorDana-Farber Cancer Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)
Christopher Manz, MD 2021. "TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04936243.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top